Healthcare Equipment and Supplies
Company Overview of ACell, Inc.
ACell, Inc. engages in the development and commercialization of extracellular matrix devices to repair and remodel damaged tissues and organs in a range of surgical procedures for the U.S. and international patents. It offers MatriStem technology, a non-crosslinked, resorbable, and acellular material; MatriStem Wound Care Matrix, a wound care device with regenerative medicine technology; MatriStem Plastic Surgery Matrix, a plastic surgery and wound care device; MatriStem Hernia Matrix, a general surgery device; and Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer that are wound management devices for the management of partial- and full-thickness wounds, including pressure ulcers, ve...
6640 Eli Whitney Drive
Columbia, MD 21046
Founded in 1999
Key Executives for ACell, Inc.
Chief Executive Officer and President
Vice President of Operations
Senior Vice President and General Counsel
Vice President of Product Development
Compensation as of Fiscal Year 2015.
ACell, Inc. Key Developments
ACell, Inc. Announces Management Changes
Jan 11 16
ACell, Inc. announced that it has named Patrick (Pat) McBrayer as President and Chief Executive Officer. McBrayer succeeds Kyle Kerbawy, who will remain as Chairman of the Board. McBrayer has more than 20 years of healthcare senior management experience. He currently serves on the Board of Directors of Misonix, Inc. and was President and CEO of AxioMed Spine Corporation until the company was acquired in 2014. McBrayer is on the Board of Directors of Misonix Inc. He has recently advised medical device companies in spine, orthopedics and biotechnology.
ACell, Inc. Introduces Cytal Wound Matrix for Complex, Full-Thickness Wounds
Jan 7 16
ACell, Inc. announced the introduction of two new wound management devices: Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer. These devices are intended for the management of partial- and full-thickness wounds including pressure ulcers, venous ulcers, diabetic ulcers, tunneled wounds, traumatic wounds, and surgical wounds. Cytal wound matrices allow for prolonged persistence of ACell's proprietary Urinary Bladder Matrix (UBM) in the wound, providing for a robust scaffold for cell infiltration and may reduce need for follow up care. The pre-fenestrated design is highly conformable in irregular wound beds and supports effective fluid management. Cytal will be available in three sizes in both 3- and 6-layer configurations. ACell's wound management portfolio also includes MicroMatrix, MatriStem Wound Matrix, MatriStem Multilayer Wound Matrix, and MatriStem Burn Matrix. ACell also manufactures and distributes a line of surgical devices including various MatriStem Surgical Matrix sheets and MatriStem Pelvic Floor Matrix.
ACell, Inc. Announces Release of MatriStem Surgical Matrix Plus
May 28 15
ACell, Inc. announced the release of MatriStem Surgical Matrix Plus, which is indicated for use in a range of surgical procedures including tissue repair, body wall repair, and hernia repair at the American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting. The product was designed to provide the strength and support needed in abdominal wall procedures, while also offering superior handling. Its reduced preparation time can also increase operating room efficiency, while its optimal and conformability make it suitable for increasingly common minimally invasive procedures. Surgical Matrix Plus will be featured in the ASCRS New Technologies Symposium, a showcase for innovative products. MatriStem Surgical Matrix Plus will be available in four sizes, and is part of the MatriStem Surgical Matrix product family, which includes Surgical Matrix RS, PSM, PSMX.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|